Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00257231 · ClinicalTrials.gov registry record

Inflammation and the Host Response to Injury (Trauma)

A clinical trial of Trauma and Burns, sponsored by Massachusetts General Hospital.

Completed
Registry status
610
Enrollment target
4
Study locations

NCT00257231: Completed study of Trauma and Burns, sponsored by Massachusetts General Hospital.

NCT00257231 is a study of Trauma and Burns that has completed, run by Massachusetts General Hospital. The registered enrollment target is 610 participants, above the 297-participant average among 56 other Trauma trials with a reported enrollment target (105% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00257231, a study of Trauma and Burns, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
610 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to help improve our understanding of the biology involved in the body's response to serious trauma or burn injury. The host response to trauma and burns is a collection of physiological and pathophysiological processes that depend critically upon the regulation of the human innate immune system, with particular emphasis on the inflammatory component of that system. No single research center or small group of centers has the capacity to delineate the integrated response of this complex biological system, which involves multiple molecular and genetic interactions that vary in time. Our proposal promotes the identification of important dynamic relationships that regulate the integration of this complex biological system, with the expectation that this understanding will ultimately impact the diagnosis, prognosis, and treatment of the hospitalized, severely injured patient.

Study Locations (4)

Colorado

  • Denver Health Medical Center at University of Colorado - Denver

Pennsylvania

  • Presbyterian University Hospital at University of Pittsburgh - Pittsburgh

Texas

  • Southwestern Medical Center at University of Texas Southwestern - Dallas

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 610 participants
Start Date 2003-11
Est. Completion 2018-09
Massachusetts General Hospital

2,032 total trials

What the finished NCT00257231 record still lists

NCT00257231 is an observational study that tracks outcomes without assigning an intervention. The registered 610 participants enrollment target is mid-sized for trials with a published cap, above the 297-participant average among 56 other Trauma trials with a reported enrollment target (105% higher).

The record links to 3 conditions, with Trauma appearing as the primary indexed condition, and to 0 interventions.

NCT00257231 reports a single indexed study location in Colorado, Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT00257231 about?

NCT00257231 is a clinical study titled "Inflammation and the Host Response to Injury (Trauma)". The purpose of this study is to help improve our understanding of the biology involved in the body's response to serious trauma or burn injury. The host response to trauma and burns is a collection of physiological and pathophysiological processes that depend critically upon the regulation of the hu...

What is the current status of trial NCT00257231?

This trial is currently completed. The enrollment target is 610 participants. The study started on 2003-11. Estimated completion is 2018-09.

What conditions does trial NCT00257231 study?

This clinical trial studies the following conditions: Trauma, Burns, Multiple Organ Failure.

Who is sponsoring clinical trial NCT00257231?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00257231 being conducted?

This trial has 4 study locations across Colorado, Pennsylvania, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00257231's enrollment target sits among peer trials

610 8th of 56 higher than 49 of 56 other Trauma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03536312 · 610 participants · NA

    Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

  • NCT05838638 · 610 participants · NA

    Serious Gaming for Chemotherapy-induced Nausea and Vomiting

  • NCT07075718 · 610 participants · Phase 2

    Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

  • NCT00823654 · 609 participants

    Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00257231, the US trial registry maintained by the National Library of Medicine. NCT00257231 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.